N/A N=44 Health Services Research

Virtual Pain Care Management (COVID-19)

Chronic Pain

Bottom Line

View on ClinicalTrials.gov: NCT04539821 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2024

Primary outcome: Primary: The Number of Patients Who Agree to Change in Their Opioid Regimen, Including Buprenorphine Transfer — 19 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: VCPM (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: VA Office of Research and Development
Primary completion: May 2021

Outcome Measures

Outcome	Result	p-value
PRIMARY The Number of Patients Who Agree to Change in Their Opioid Regimen, Including Buprenorphine Transfer	19	—
SECONDARY Number of Participants Retained in Care at End of Study	17	—

Summary

The COVID-19 pandemic is exacerbating the challenges faced by Veterans at risk of opioid overdose including Veterans prescribed moderate-to-high dose long-term opioid therapy (LTOT) whose usual treatment resources and coping strategies may be inaccessible. This project combines established VA care components to deploy and evaluate virtual models of care for Veterans on high-risk LTOT to meet the dual challenges of maintaining social distancing and delivery high quality care.

Eligibility Criteria

Inclusion Criteria

Eligible participants must currently receive LTOT for chronic pain at 50 mg morphine equivalent daily dose

Exclusion Criteria

Exclusion criteria at baseline are:

dementia diagnosis or moderate-severe cognitive impairment
unstable or severe untreated psychiatric disorder or medical disease that requires hospitalization
documentation of suspected controlled substance diversion
inability to communicate by phone

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04539821). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.